Ep. 107: “Immune Cell Manipulation” Featuring Dr. Rizwan Romee
From The Immunology Podcast · · 1 hr 11 min
This plays from the publisher's own server. We do not host a copy.
Description
Guest:
Dr. Rizwan Romee is a Oncologist at the Dana-Farber Cancer Institute and Associate Professor at Harvard Medical School, where his research focuses on genetically manipulating NK cells to enhance their anti-tumor function. He talks about advances and challenges in engineering NK cells for cancer therapy. He also discusses using E. coli to deliver immune-activating cytokines to tumors (https://www.nature.com/articles/s41587-024-02418-6?elqTrackId=5ba94c72b542406cb3001b8341341581). (37:31)
Featured Products and Resources:
- Register now for IUIS 2025! (https://iuis2025.org/)
- Enter to win a personalized lab coat! (http://www.stemcellsciencenews.com/giveaway?utm_source=scpodcast&utm_medium=banner)
The Immunology Science Round Up
The Y Chromosome in Cancer (https://www.nature.com/articles/s41586-025-09071-2) – Loss of the Y chromosome in tumor and T cells worsens survival. (5:00)
Boosting CD8 T Cell Responses (https://www.science.org/doi/10.1126/sciimmunol.ads1328) – Cytokine-adjuvanted mRNA-lipid nanoparticles can enhance immune response to vaccination. (11:40)
Bacterial Antitumor Immunotherapy (https://www.cell.com/immunity/abstract/S1074-7613(25)00194-3) – Intratumoral Listeria monocytogenes can either enhance or inhibit tumor progression. (21:30)
NK Cell Signaling (https://www.nature.com/articles/s41586-025-09087-8) – CAR activation and IL-15 signaling rapidly induce CREM upregulation in NK cells. (28:20)
Subscribe to our newsletter!
Never miss updates about new episodes.
Subscribe